4/A
Changes in Ownership
Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000109
10% owner acquired 115,131 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion | +71,090 | $2.60 | $184,834 | 2,055,706 | D |
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion | +44,041 | $2.60 | $114,507 | 2,099,747 | D |
| Derivatives | |||||||
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion · Convertible Promissory Note | +0 | 0 | D | ||
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion · Convertible Promissory Note | +0 | 0 | D | ||
Loading xslF345X05/primary_doc.xml…